Supplements9 min read
Tongkat ali and testosterone: which outcome actually improved?
Tongkat ali trials differ in age, extract and outcomes. Understand testosterone findings, symptom evidence and the unresolved safety concern.
Read articleBlog
Research, explained. Explore peptides, supplements, hormone health, longevity and red light therapy with clear, practical breakdowns of what the studies actually tell us.
Explore the articles
Find a topic you’re curious about and take a closer look.
Supplements8 min read
Magnesium for sleep: start with the problem, then the evidence
Magnesium may modestly improve sleep symptoms for some adults. The useful first step is identifying the sleep problem and understanding what trials measured.
Read article
Supplements9 min read
Does an athlete need a different multivitamin—or a clearer nutrition assessment?
Sport branding does not diagnose a nutrient gap. Athlete studies, iron-deficiency research and food-intake trials point to a more specific assessment.
Read article
Peptides9 min read
Mazdutide and uric acid: a promising blood result is not yet a gout claim
Mazdutide lowered serum urate in obesity trials. The original results support a focused research question, not an established gout-treatment claim.
Read article
Peptides9 min read
Eloralintide and cagrilintide: meaningful differences without a premature winner
The drugs share an amylin starting point but differ in receptor activity and clinical evidence. Separate trials cannot establish a winner.
Read article
Peptides8 min read
What would make petrelintide useful in everyday care?
Published phase 2 findings move petrelintide beyond an early signal. Routine care needs a fuller account of who benefits, what persists and how treatment feels.
Read article
Peptides9 min read
BPC-157's infusion pilot: what two participants can tell us
BPC-157's intravenous pilot followed two previously exposed adults for three days. Its observations leave uncommon, delayed and product-specific risks unresolved.
Read article
Supplements9 min read
Creatine for Alzheimer's: what the 2025 pilot can tell families
The Alzheimer's creatine pilot found higher brain creatine and changes on cognitive tests. Its uncontrolled design leaves treatment benefit unresolved.
Read article
Peptides9 min read
Does feeling more energetic show that SS-31 improved mitochondria?
Feeling better, walking farther and producing ATP are different outcomes. Human elamipretide studies show why symptoms cannot identify a mitochondrial mechanism.
Read article
Peptides8 min read
GHRP-2 and growth-hormone deficiency: what treatment studies show
Early pediatric studies suggested a growth response, but a larger randomized trial did not confirm a benefit. Diagnosis and treatment outcomes need separate interpretation.
Read article
Peptides8 min read
Research PT-141 and prescription bremelanotide: what differs?
A shared ingredient name does not establish the same formulation, quality controls, or clinical evidence.
Read article
Peptides9 min read
Oxytocin is not simply the “trust hormone”
Original experiments, failed replications and a positive 2026 study in low-trusting men tell a more specific story than the nickname.
Read article410–421 of 600 articles